Related Experiment Videos
Abnormalities of in vitro thyroid function tests in renal disease
The Quarterly Journal of Medicine
|April 1, 1974
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Subcutaneous Administration of Otelixizumab is Limited by Injection Site Reactions: Results of an Exploratory Study in Type 1 Diabetes Mellitus Patients.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2016
Urinary C-peptide analysis in an intervention study: experience from the DEFEND-2 otelixizumab trial.
Diabetic medicine : a journal of the British Diabetic Association·2016
Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study.
Diabetic medicine : a journal of the British Diabetic Association·2013
Asthma control in a random sample of New Zealand adolescent asthmatics.
The Journal of asthma : official journal of the Association for the Care of Asthma·2007
Developing alternative devices to the long-term urinary catheter for draining urine from the bladder.
Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine·2003
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026